EU Reg 2020/354 Part B Entry 11 — Reduction of oxalate stones formation
Species: Dogs and cats
Purpose (essential nutritional characteristics): Reduction of oxalate stones formation — Low level of calcium, low level of vitamin D, and urine alkalising properties
Duration of use: Up to 6 months
Source: EU Reg 2020/354 Part B (consolidated text per EUR-Lex CELEX:02020R0354, version 2025-04-22). Entry 11 is part of the 44 PARNUT entries in Part B (range 10-72). Cross-references: AAFCO nutrition profiles for chronic kidney disease, cardiac disease, dermatological conditions. FEDIAF nutritional guidelines 2025 provide complementary guidance but do not authorize therapeutic claims — EU 2020/354 is required for products marketed with PARNUT claims.
Notes: This entry is part of the 44-entry block (10-30 + 50-72). Entries 31-49 are not used in the current consolidated text (numbering jumps from 30 to 50). Always consult official EUR-Lex consolidated 2020/354 text when preparing EU-market petitions for products covered by Entry 11.